|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date | Status |
|---|---|---|
| Ischemic heart disease | 06-Aug-2022 | active |
| Osteoarthritis of knee | 24-Oct-2021 | active |
| Prediabetes | 20-Aug-2005 | active |
| Anemia | 20-Aug-2005 | active |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Acetaminophen 325 mg oral tablet | 2024-08-17 | - | 1 tablet (325 mg) by mouth every 4 to 6 hours as needed | - |
| Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2022-08-13 | - | 1 tablet (75 mg) once daily | - |
| Simvastatin 20 mg oral tablet | 2022-08-13 | - | 1 tablet (20 mg) by mouth once daily | - |
| Nitroglycerin 400 microgram/actuation sublingual spray | 2022-08-13 | - | 400 micrograms (1 spray) under the tongue as needed for chest pain, repeat every 5 minutes if needed, up to 3 sprays in 15 minutes | - |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2022-08-13 | - | 1 tablet (100 mg) once daily | - |
| Naproxen sodium 220 mg oral capsule | 2021-10-24 | - | 1 tablet (220 mg) by mouth every 12 hours as needed | Osteoarthritis of knee |
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 17-Aug-2024 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 06-Aug-2022 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 06-Aug-2022 |
| SARS-CoV-2 mRNA vaccine | 10-Apr-2021 |
| Procedure | Date | Reason |
|---|---|---|
| Medication reconciliation | 16-Mar-2019 | - |
| Assessment of health and social care needs | 16-Mar-2019 | - |
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Musculoskeletal care | 24-Oct-2021 | Osteoarthritis of knee |
|
||
| Diabetes self management plan | 20-Aug-2005 | Prediabetes |
|
| Vital Signs | 2024-08-17 | 2023-08-12 |
|---|---|---|
| Body Height | 190.2 cm | 190.2 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 {score} | 4 {score} |
| Body Weight | 109.7 kg | 109.7 kg |
| Body mass index (BMI) [Ratio] | 30.3 kg/m2 | 30.3 kg/m2 |
| Diastolic Blood Pressure | 51 mm[Hg] | 44 mm[Hg] |
| Systolic Blood Pressure | 95 mm[Hg] | 85 mm[Hg] |
| Heart rate | 75 /min | 96 /min |
| Respiratory rate | 15 /min | 16 /min |
| Recent Lab Observations | 17-AUG-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | 4.3 - 6.4 | % |
| Glucose [Mass/volume] in Blood | 90.3 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 7.2 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.4 H | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.0 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 136.6 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 5.1 | 3.5 - 5.3 | mmol/L |
| Chloride [Moles/volume] in Blood | 110.0 | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 28.8 | 22 - 29 | mmol/L |
| Device | Date (since) |
|---|---|
| Wheelchair accessory (physical object) | 24-Oct-2021 |
| Power-assisted wheelchair (physical object) | 24-Oct-2021 |
| Blood glucose meter (physical object) | 20-Aug-2005 |